Submission Details
| 510(k) Number | K212193 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 14, 2021 |
| Decision Date | October 22, 2021 |
| Days to Decision | 100 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K212193 is an FDA 510(k) clearance for the Terragene Bionova SCBI (BT96), Terragene Bionova Reader Incubators (IC10/20FRLCD, Mini-bio), Terragene Chemdye (CD42), Terragene Cintape (CT40), a Indicator, Biological Sterilization Process (Class II — Special Controls, product code FRC), submitted by Plasmapp Co,., Ltd. (Daejeon, KR). The FDA issued a Cleared decision on October 22, 2021, 100 days after receiving the submission on July 14, 2021. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.2800.
| 510(k) Number | K212193 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 14, 2021 |
| Decision Date | October 22, 2021 |
| Days to Decision | 100 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | FRC — Indicator, Biological Sterilization Process |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.2800 |